Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Sarcoma
2		Additional conditions recognized in this trial
			Neuroectodermal Tumors
			Sarcoma, Ewing's
3		More general conditions related to this trial
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms, Bone Tissue
			Neoplasms, Connective and Soft Tissue
			Neoplasms, Connective Tissue
			Neoplasms, Germ Cell and Embryonal
			Neoplasms, Nerve Tissue
			Osteosarcoma
4		Interventions listed in this trial
			cyclophosphamide
			doxorubicin hydrochloride
			etoposide
			filgrastim
			ifosfamide
			vincristine
			adjuvant therapy
			brachytherapy
			conventional surgery
			neoadjuvant therapy
			radiation therapy
5		Additional drug interventions recognized in this trial
			Doxorubicin
6		More general drug interventions related to this trial
			Alkylating Agents
			Antibiotics, Antineoplastic
			Antimitotic Agents
			Antineoplastic Agents
			Antineoplastic Agents, Alkylating
			Antineoplastic Agents, Phytogenic
			Antirheumatic Agents
			Immunologic Factors
			Immunosuppressive Agents
			Mitosis Modulators
			Molecular Mechanisms of Pharmacological Action
			Myeloablative Agonists
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
			Tubulin Modulators
7		Sponsors listed in this trial
			Children's Oncology Group
			National Cancer Institute (NCI)
			Southwest Oncology Group